AIA
ELV icon

Allegis Investment Advisors’s Elevance Health ELV Stock Holding History

Allegis Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-706
Closed -$98K – 375
2015
Q4 		$98K Buy
+706
New +$97.3K 0.05% 225

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allegis Investment Advisors's ELV Position: Q1 2016 in Review

Allegis Investment Advisors sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 706 shares — an estimated $98K sold.

Allegis Investment Advisors first reported a position in ELV in Q4 2015 and held it in 1 quarter. The position peaked at $98K in Q4 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • Allegis Investment Advisors reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 706 Elevance Health shares in Q1 2016, an estimated $98K.
  • Allegis Investment Advisors first reported a position in Elevance Health in Q4 2015 and held it in 1 quarter.
  • Allegis Investment Advisors's Elevance Health position peaked at $98K in Q4 2015.
  • 770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Allegis Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.